Updated Jul 16, 2026
DeMuth Peter is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-03 | ELTX | Elicio Therapeutics, Inc. | A — Grant or award | 20.8K | $0.00 | |
| 2024-12-18 | ELTX | Elicio Therapeutics, Inc. | M — Option exercise | 381 | $4.41 | $2K |
DeMuth Peter is a corporate insider — currently tracked as Chief Scientific Officer. InsiderAlpha tracks every SEC Form 4 filing in real time.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live DeMuth Peter profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.